Impact Factor
7.883
Call For Paper
Volume 12 Issue 07
July 2026
Download Paper Format
Copyright Form
Author(s)
Blessan. Y. R P. Briskilla
Abstract
The Successful Development Of Amyloid- Based Biomarkers And Tests For Alzheimer’s Disease (AD) Represents An Important Milestone In AD Diagnosis. How- Ever, Two Major Limitations Remain. Amyloid-based Diagnos- Tic Biomarkers And Tests Provide Limited Info
Keywords
Alzheimer’s Disease
Blood Biomarker
Dementia
Machine Learning
Support Vector Machine.
Paper ID
IJSARTV8I956790
Publication Date
September 2, 2022
Research Area
Computer Science And Engineering